Activated Amino Acid Response Pathway Generates Apatinib Resistance by Reprograming Glutamine Metabolism in Non-Small-Cell Lung Cancer

The authors demonstrated that apatinib could reprogram glutamine metabolism in human NSCLC via a mechanism involved in amino acid metabolic imbalances.